M Souvatzoglou1, T Maurer, U Treiber, G Weirich, B J Krause, M Essler. Show Affiliations » 1. Department of Nuclear Medicine, Klinikum-rechts-der-Isar, Muenchen, Germany.
Abstract
Entities: Disease
Mesh： See more » Anilides/therapeutic useAntineoplastic Agents/therapeutic useCell DifferentiationCisplatin/therapeutic useEtoposide/therapeutic useHumansMaleMiddle AgedNitriles/therapeutic useOctreotide/analogs & derivativesPositron-Emission TomographyProstate-Specific Antigen/bloodProstatic Neoplasms/bloodProstatic Neoplasms/diagnostic imagingProstatic Neoplasms/drug therapyProstatic Neoplasms/pathologyRadiopharmaceuticalsTomography, X-Ray Computed/methodsTosyl Compounds/therapeutic use
Substances： See more » AnilidesAntineoplastic AgentsNitrilesRadiopharmaceuticalsTosyl CompoundsEtoposidebicalutamideProstate-Specific AntigenCisplatinOctreotideEdotreotide
Year: 2009 PMID： 20512196
Source DB: PubMed Journal: Nuklearmedizin ISSN： 0029-5566 Impact factor: 1.379